[The treatment of severe and recurrent nonspecific colpitis].
Attention is drawn to the incidence of colpitis and the symptom of "vaginal discharge" in the gynaecological field, as well as to the required investigations as far as differential diagnosis is concerned. Severe, purulent, unspecific colpitis and also recurrent colpitis require particularly careful treatment. Excellent therapeutic results have been achieved over many years with repeated local administration of TC-Gel-Steraject and, if necessary, additional treatment with an oestriol preparation; this therapy is therefore recommended.
D000287:Administration, Topical; D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D004338:Drug Combinations; D004964:Estriol / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006854:Hydrocortisone; D007973:Leukorrhea / Q000188:drug therapy; D008875:Middle Aged; D010118:Oxytetracycline / Q000627:therapeutic use*; D011113:Polymyxins / Q000627:therapeutic use*; D014627:Vaginitis / Q000188:drug therapy*
D000893:Anti-Inflammatory Agents; D004338:Drug Combinations; D011113:Polymyxins; D004964:Estriol; D006854:Hydrocortisone; D010118:Oxytetracycline
Zur Behandlung der schweren und rezidivierenden unspezifischen Kolpitis.